Page 35 - MI-2-3
P. 35

Microbes & Immunity                                                    Correlation between VZV and cancer



            36.  Sebastian AP, Basu A, Mitta N, Benjamin D. Transverse   differential expression of pro-  and antiapoptosis genes by
               myelitis  caused  by  varicella-zoster.  BMJ  Case  varicella-zoster  virus-infected neurons  and fibroblasts.
               Rep. 2021;14(8):e243217.                           J Virol. 2014;88(13):7674-7677.
               doi: 10.1136/bcr-2020-238078                       doi: 10.1128/JVI.00500-14
            37.  Mirouse A, Vignon P, Piron P, et al. Severe varicella-zoster   48.  Wong RS. Apoptosis in cancer: From pathogenesis to
               virus  pneumonia:  A  multicenter  cohort  study.  Crit Care.   treatment. J Exp Clin Cancer Res. 2011;30(1):87.
               2017;21(1):137.
                                                                  doi: 10.1186/1756-9966-30-87
               doi: 10.1186/s13054-017-1731-0
                                                               49.  Chen X, Duan N, Zhang C, Zhang W. Survivin and
            38.  Cao LJ, Zheng YM, Li F, Hao HJ, Gao F. Varicella-zoster   tumorigenesis: Molecular mechanisms and therapeutic
               virus meningitis with hypoglycorrhachia: A  case report.   strategies. J Cancer. 2016;7(3):314-323.
               World J Clin Cases. 2023;11(29):7101-7106.
                                                                  doi: 10.7150/jca.13332
               doi: 10.12998/wjcc.v11.i29.7101
                                                               50.  Ge J, Wang Y, Li X, et al. Phosphorylation of caspases by
            39.  Eleftheriou  D,  Moraitis  E,  Hong  Y,  et al.  Microparticle-  a bacterial kinase inhibits host programmed cell death. Nat
               mediated VZV propagation and endothelial activation:   Commun. 2024;15(1):8464.
               Mechanism   of  VZV    vasculopathy.  Neurology.
               2020;94(5):e474-e480.                              doi: 10.1038/s41467-024-52817-1
                                                               51.  Albadari N, Li W. Survivin small molecules inhibitors:
               doi: 10.1212/WNL.0000000000008885
                                                                  Recent advances and challenges. Molecules. 2023;28(3):1376.
            40.  Hertzog J, Zhou W, Fowler G, et al. Varicella-Zoster virus
               ORF9 is an antagonist of the DNA sensor cGAS. EMBO J.      doi: 10.3390/molecules28031376
               2022;41(14):e109217.                            52.  Warrier NM, Agarwal P, Kumar P. Emerging importance of
               doi: 10.15252/embj.2021109217                      survivin in stem cells and cancer: The development of new
                                                                  cancer therapeutics. Stem Cell Rev Rep. 2020;16(5):828-852.
            41.  Zahid A, Ismail H, Li B, Jin T. Molecular and structural
               basis of DNA sensors in antiviral innate immunity.  Front      doi: 10.1007/s12015-020-09995-4
               Immunol. 2020;11:613039.                        53.  Aggarwal D, Shetty DC, Jain A, Gulati N, Juneja S.
               doi: 10.3389/fimmu.2020.613039                     Pathogenetic model of survivin-dependent molecular
                                                                  signalling pathways in tumorigenesis of oral cancer and
            42.  Liu H, Zhang H, Wu X,  et al. Nuclear cGAS suppresses   precursor lesions.  J  Oral Maxillofac Pathol. 2023;27(2):
               DNA  repair  and  promotes  tumorigenesis.  Nature.   287-294.
               2018;563(7729):131-136.
                                                                  doi: 10.4103/jomfp.jomfp_5_23
               doi: 10.1038/s41586-018-0629-6
                                                               54.  Liu T, Brouha B, Grossman D. Rapid induction of
            43.  Du JM, Qian MJ, Yuan T, et al. cGAS and cancer therapy:   mitochondrial events and caspase-independent apoptosis
               A  double-edged sword.  Acta Pharmacol Sin. 2022;43(9):   in Survivin-targeted melanoma cells. Oncogene. 2004;23(1):
               2202-2211.                                         39-48.
               doi: 10.1038/s41401-021-00839-6                    doi: 10.1038/sj.onc.1206978
            44.  Nguyen LN, Kanneganti TD. PANoptosis in viral infection:   55.  Moffat JF, Greenblatt RJ. Effects of varicella-zoster virus on
               The missing puzzle piece in the cell death field. J Mol Biol.   cell cycle regulatory pathways. Curr Top Microbiol Immunol.
               2022;434(4):167249.                                2010;342:67-77.
               doi: 10.1016/j.jmb.2021.167249                     doi: 10.1007/82_2010_28
            45.  Kennedy PG, Graner MW, Gunaydin D, Bowlin J, Pointon T,   56.  Kovalishyn V, Severin O, Kachaeva M, et al. In silico design
               Yu X. Varicella-Zoster Virus infected human neurons are   and experimental validation of  novel oxazole  derivatives
               resistant to apoptosis. J Neurovirol. 2020;26(3):330-337.  against varicella zoster virus.  Mol Biotechnol. 2024;66(4):
               doi: 10.1007/s13365-020-00831-6                    707-717.
            46.  Steain M, Slobedman B, Abendroth A. Modulation of      doi: 10.1007/s12033-023-00670-w
               apoptosis and cell death pathways by varicella-zoster virus.   57.  Traves R, Opadchy T, Slobedman B, Abendroth A. Varicella
               Curr Top Microbiol Immunol. 2023;438:59-73.
                                                                  zoster virus downregulates expression of the nonclassical
               doi: 10.1007/82_2021_249                           antigen presentation molecule CD1d.  J  Infect Dis.
                                                                  2024;230(2):e416-e426.
            47.  Markus A, Waldman Ben-Asher H, Kinchington PR,
               Goldstein RS. Cellular transcriptome analysis reveals      doi: 10.1093/infdis/jiad512


            Volume 2 Issue 3 (2025)                         27                               doi: 10.36922/mi.8320
   30   31   32   33   34   35   36   37   38   39   40